Discern Health And NPC Host Webinar On Strategies To Improve Oncology Measurement

May 2017

Discern Partner Tom Valuck discusses the White Paper with Kimberly Westrich, NPC VP of Health Services Research
On April 26, Discern Health partnered with the National Pharmaceutical Council (NPC) to host a webinar discussing the findings of the recently published “Improving Oncology Quality Measurement in Accountable Care” white paper.

The webinar, which was moderated by NPC Vice President of Health Services Research Kimberly Westrich and featured Discern Health Partner Tom Valuck, discussed identified measure gaps for 10 high-priority cancers and potential avenues to improve measurement. Three experts in quality measurement and oncology reacted to the findings:

  • Mark McClellan, MD, PhD, director of the Duke-Margolis Center for Health Policy
  • Robert S. Miller, MD, FACP, FASCO, vice president and medical director, CancerLinQ at the American Society of Clinical Oncology (ASCO)
  • Alan Balch, PhD, chief executive officer at the National Patient Advocate Foundation.

Click here to access a recording and slide presentation from the April 26 webinar. To learn more about the project, contact Tom Valuck or David Blaisdell.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO